Aspirin-induced Long Non-coding RNA Suppresses Colon Cancer Growth

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2022 Feb 4

PMID 35116527

Authors

Mingwei Chen

Lili Wu

Huajie Zhan

Tonghua Liu

Yan He

Affiliations

Soon will be listed here.

Abstract

Background: To study the effect of long non-coding RNAs (lncRNA) on aspirin-treated colon cancer cells.

Methods: To study the changes of lncRNA in aspirin-treated colon cells by microarray analysis, real-time quantitative PCR (qPCR) was used to verify the expression of selected lncRNA and mRNA. The effects of aspirin on the proliferation and metastasis of the siRNA transfected cells and control colon cancer cells were detected by Cell Counting Kit-8 (CCK-8) and Transwell experiments. Bioinformatics tools were employed to analyze the potential function of lncRNA.

Results: Compared with the control group, aspirin inhibited the proliferation and metastasis of colon cancer cells. Microarray analysis showed that a total of 10,568 lncRNAs and 22,126 mRNAs were noticeably expressed in the aspirin-treated group (≥1.5-fold, P<0.05). The qPCR results showed that lncRNA and mRNA expressions were consistent with microarray analysis. The analysis of the co-expression network profiles of 58 lncRNA and 101 mRNA differential genes showed a total of 158 nodes and 791 connections. Analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways revealed that a variety of lncRNAs (NEAT1, LOC152578) were involved in the inhibition mechanism of aspirin in colon cancer.

Conclusions: lncRNA NEAT1 and LOC152578 are involved in the inhibition of tumor cell growth and metastasis by aspirin. The results of these analyses will help us further understand the mechanism of action of aspirin and the roles of lncRNAs in the prevention and treatment of colon cancer.

Citing Articles

Pathway Polygenic Risk Scores (pPRS) for the Analysis of Gene-environment Interaction.

Gauderman W, Fu Y, Queme B, Kawaguchi E, Wang Y, Morrison J bioRxiv. 2025; .

PMID: 39763728 PMC: 11702571. DOI: 10.1101/2024.12.16.628610.

LncRNAs in Kawasaki disease and Henoch-Schönlein purpura: mechanisms and clinical applications.

Yang K, Tang J, Li H, Zhang H, Ding J, Li Z Mol Cell Biochem. 2023; 479(8):1969-1984.

PMID: 37639198 DOI: 10.1007/s11010-023-04832-x.

Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited.

Hall D, Benndorf R Cell Mol Life Sci. 2022; 79(7):393.

PMID: 35780223 PMC: 9250486. DOI: 10.1007/s00018-022-04430-y.

Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease.

Vlachogiannis N, Sachse M, Georgiopoulos G, Zormpas E, Bampatsias D, Delialis D J Mol Cell Cardiol. 2021; 160:111-120.

PMID: 34302813 PMC: 8585018. DOI: 10.1016/j.yjmcc.2021.07.005.

References

Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

Clemson C, Hutchinson J, Sara S, Ensminger A, Fox A, Chess A . An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell. 2009; 33(6):717-26. PMC: 2696186. DOI: 10.1016/j.molcel.2009.01.026. View

Hua H, Zhang H, Kong Q, Wang J, Jiang Y . Complex roles of the old drug aspirin in cancer chemoprevention and therapy. Med Res Rev. 2018; 39(1):114-145. DOI: 10.1002/med.21514. View

Tian T, Wang M, Lin S, Guo Y, Dai Z, Liu K . The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis. Mol Ther Nucleic Acids. 2018; 12:359-369. PMC: 6037885. DOI: 10.1016/j.omtn.2018.05.018. View

Flossmann E, Rothwell P . Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 2007; 369(9573):1603-13. DOI: 10.1016/S0140-6736(07)60747-8. View

Peng C, Zhao X, Wei C, Wu J . LncRNA HOTAIR promotes colon cancer development by down-regulating miRNA-34a. Eur Rev Med Pharmacol Sci. 2019; 23(13):5752-5761. DOI: 10.26355/eurrev_201907_18312. View

Ding D, Li C, Zhao T, Li D, Yang L, Zhang B . LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling. Mol Cells. 2018; 41(5):423-435. PMC: 5974619. DOI: 10.14348/molcells.2018.2258. View

DiDonato J, Mercurio F, Karin M . NF-κB and the link between inflammation and cancer. Immunol Rev. 2012; 246(1):379-400. DOI: 10.1111/j.1600-065X.2012.01099.x. View

Anantharaman A, Jadaliha M, Tripathi V, Nakagawa S, Hirose T, Jantsch M . Paraspeckles modulate the intranuclear distribution of paraspeckle-associated Ctn RNA. Sci Rep. 2016; 6:34043. PMC: 5036046. DOI: 10.1038/srep34043. View

10.

Iyer M, Niknafs Y, Malik R, Singhal U, Sahu A, Hosono Y . The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015; 47(3):199-208. PMC: 4417758. DOI: 10.1038/ng.3192. View

11.

Zou K, Hu Y, Li M, Wang H, Zhang Y, Huang L . Potential Role of HMGCS2 in Tumor Angiogenesis in Colorectal Cancer and Its Potential Use as a Diagnostic Marker. Can J Gastroenterol Hepatol. 2019; 2019:8348967. PMC: 6634068. DOI: 10.1155/2019/8348967. View

12.

Hardy R, Meltzer S, Jankowski J . ABC of colorectal cancer. Molecular basis for risk factors. BMJ. 2000; 321(7265):886-9. PMC: 1118685. DOI: 10.1136/bmj.321.7265.886. View

13.

Kim J, Li C, Weiss H, Zhou Y, Liu C, Wang Q . Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells. Cells. 2019; 8(9). PMC: 6770209. DOI: 10.3390/cells8091106. View

14.

Shi M, Liu D, Duan H, Han C, Wei B, Qian L . Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer. Mol Cancer. 2010; 9:269. PMC: 2964618. DOI: 10.1186/1476-4598-9-269. View

15.

Zhu Y, Yang C, Weng M, Zhang Y, Yang C, Jin Y . Identification of TMEM208 and PQLC2 as reference genes for normalizing mRNA expression in colorectal cancer treated with aspirin. Oncotarget. 2017; 8(14):22759-22771. PMC: 5410260. DOI: 10.18632/oncotarget.15191. View

16.

Alfonso L, Ai G, Spitale R, Bhat G . Molecular targets of aspirin and cancer prevention. Br J Cancer. 2014; 111(1):61-7. PMC: 4090734. DOI: 10.1038/bjc.2014.271. View

17.

Yamada A, Yu P, Lin W, Okugawa Y, Boland C, Goel A . A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer. Sci Rep. 2018; 8(1):575. PMC: 5766599. DOI: 10.1038/s41598-017-18407-6. View

18.

Langley R . Clinical evidence for the use of aspirin in the treatment of cancer. Ecancermedicalscience. 2013; 7:297. PMC: 3622409. DOI: 10.3332/ecancer.2013.297. View

19.

Camarero N, Mascaro C, Mayordomo C, Vilardell F, Haro D, Marrero P . Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer. Mol Cancer Res. 2006; 4(9):645-53. DOI: 10.1158/1541-7786.MCR-05-0267. View

20.

Rothwell P, Wilson M, Elwin C, Norrving B, Algra A, Warlow C . Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010; 376(9754):1741-50. DOI: 10.1016/S0140-6736(10)61543-7. View